4CPS-228 Effectiveness and security of new direct-acting antiviral agents for hcv

BACKGROUND: New direct-acting antivirals (DAAs) for chronic hepatitis C have been marketed and have changed the therapeutic landscape of this pathology. PURPOSE: To assess the effectiveness and security of new direct-acting antiviral agents for HCV. MATERIAL AND METHODS: Retrospective study carried...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Hosp Pharm
Main Authors: Marín, L Martínez Dueñas López, González, E González, Bonilla, AManzano, Romero, ACaballero, Sacristán, EGalindo, Chica, FMalpica, Romera, MCamacho
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2018
Assuntos:
Section 4: Clinical pharmacy services
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535611/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.318
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados